blog.profil.comProfil — Clinical trials in diabetes

English - United States Chinese Patient information Jobs Blog Organization About Profil Driving innovation in diabetes Meet us at conferences News People Board of Shareholders Executive team Scientists Career Job profiles Open positions Your Application Training as clinical pharmacologist Training as study nurse Research Focus Diabetes treatment Glucose lowering medication Alternative route insulins Insulin analogues Diabetes complications Incretin hormones Medical technology Insulin pump Artificial pancreas Glucose meters Continuous glucose monitoring Obesity treatment Obesity Impaired glucose tolerance NAFLD / NASH Cardiometabolic research Clinical Trial Services Clinical development Bioequivalence / biosimilar Pharmacodynamics Pharmacokinetics Bridging studies Safety and tolerability Methods Glucose clamp Bodpod / body composition Pancreatic clamp Stable isotopes / metabolic fluxes Adipose tissue and muscle biopsy Transient elastography Flow-mediated dilation Retinal laser scanner Skin laser Doppler Standardized food intake / Nutrition Exercise / energy expenditure Other methods Further services Patient recruitment GMP certified pharmacy Data management, statistics and medical writing Regulatory handling Clinical development consulting Knowledge Center Scientific content Publications Online Seminars Blog Conference Posters Diabetes Knowledge Diabetes types Diabetes prevention Stem cells Trial stages Modal Title Any content could go in here. × On-Demand Online Seminar Click here to watch our latest on-demand online seminar, titled: "IMP management services for multi and single-center clinical trials in EU". Watch now Meet us at ADA 2024 Are you planning a clinical trial? Meet us in Orlando, FL, USA, at the ADA 84th Scientific Session in June 2024 to discuss next steps. Meet Profil ClampArt® Learn about the next-generation glucose clamp technology that makes Profil the world’s leading glucose clamp site. Read more About Profil Discover the capabilities and expertise of Profil. Read more Medical Technology Profil has a dedicated department for clinical trials of diabetes-related medical devices. Read more Diabetes Treatment Profil is the partner of choice for clinical studies of diabetes treatment s. Read more News at Profil Download our recent conference posters for free. Profil is the world’s leading full-service CRO for diabetes and obesity research. As a full-service CRO for early clinical trials in diabetes and obesity, Profil has brought together regulatory and scientific experts so that we can offer you unrivalled service. We focus that expertise on developing sophisticated experimental methods, optimizing study designs, and delivering critical answers for further compound development. Profil began life as a spin-off of an academic study group at the Department of Metabolic Diseases and Nutrition at the University of Düsseldorf. Our founders wished to create a dedicated CRO that would address the challenges of diabetes and obesity research and treatment. The company’s achievements are testament to that vision. Over the years, we have implemented numerous sophisticated methods for pharmacodynamic characterization of the effects of compounds in early phase trials, and we have been involved in the development of all the currently available major anti-diabetic compounds. Our key competence is the performance of glucose clamp studies, often combined with isotope dilution techniques and muscle or fat biopsies. Read more References We have published with the following sponsors: - Boehringer Ingelheim - Eli Lilly - Novo Nordisk - SanofiView more Certificates ISO 13485:2016 ISO 27001 Update 13.12.2022: jetzt BVMA Logo ISO 9001:2015 BVMA Member Publications Leohr J. et al., 2020. Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog ® (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study, Clinical Pharmacokinetics, Dec; 59 (12): 1601-1610 (2020) View all Expertise Diabetes Treatment Medical Technology Obesity Services Diabetes Medication Development Methods Further Services Knowledge Centre Publications Online Seminars Blog Diabetes Knowledge Organization About Profil People Career Profil is the leading clinical research organisation for studies related to diabetes and obesity. We conduct pharmacodynamics, pharmacokinetics, biosimilar, safety and tolerability studies, as well as bridging studies and more. We have been involved in the development of an artificial pancreas as part of the AP@home project and have been invovled in the development of all classes of antidiabetic drugs. If you are developing treatments for diabetes mellitus type 1 or diabetes mellitus type 2, then Profil is the right partner for you. Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 · D-41460 Neuss Telefon (02131) 4018-345 · info@profil.com Imprint | Privacy Policy | Contact © 2024 Profil Institut für Stoffwechselforschung...